Gene: ANKMY2
Official Full Name: ankyrin repeat and MYND domain containing 2provided by HGNC
Gene Summary: Predicted to enable enzyme binding activity and metal ion binding activity. Predicted to be located in cilium. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19861 | ANKMY2 Knockout cell line (HeLa) | Human | ANKMY2 | 1:3~1:6 | Negative | Online Inquiry |
KO19862 | ANKMY2 Knockout cell line (HCT 116) | Human | ANKMY2 | 1:2~1:4 | Negative | Online Inquiry |
KO19863 | ANKMY2 Knockout cell line (HEK293) | Human | ANKMY2 | 1:3~1:6 | Negative | Online Inquiry |
KO19864 | ANKMY2 Knockout cell line (A549) | Human | ANKMY2 | 1:3~1:4 | Negative | Online Inquiry |
ANKMY2 Gene Knockout Cell Lines are specialized cellular systems engineered to express a non-functional variant of the ANKMY2 gene, a crucial component associated with various biological processes, including cellular signaling and intracellular transport. This gene knockout establishes a valuable tool for studying the specific roles of ANKMY2 in health and disease settings, allowing researchers to dissect gene function and identify pathways affected by its absence.
The primary function of these cell lines is to facilitate the investigation of the ANKMY2 gene’s contribution to cellular mechanisms at a molecular level. By utilizing CRISPR-Cas9 technology for the gene knockout, these cell lines ensure a high efficiency in disabling the target gene, leading to observable phenotypic changes. Researchers can assess alterations in cellular behavior, signaling pathways, and gene expression profiles that result from the knockout, thereby gaining insight into the biological significance of ANKMY2 in various contexts.
The scientific relevance of ANKMY2 Gene Knockout Cell Lines extends to multiple research fields, including cancer biology, neurobiology, and developmental biology. Their application in preclinical studies can guide therapeutic strategies targeting ANKMY2-related pathways, potentially leading to new treatments for diseases where this gene plays a role. Moreover, these cell lines can serve as essential platforms for drug discovery or the evaluation of genetic interactions, making them indispensable for translational research.
What sets ANKMY2 Gene Knockout Cell Lines apart from alternatives is their unmatched specificity and reliability. The precision CRISPR editing, coupled with comprehensive validation of the knockout, assures researchers of consistent results in their experiments. Additionally, their easy integration into existing laboratory workflows enhances their usability across various research settings.
For researchers and clinicians committed to advancing our understanding of genetic mechanisms, ANKMY2 Gene Knockout Cell Lines offer unparalleled value, enabling in-depth exploration and potential breakthroughs in therapeutic interventions. Our company is renowned for its commitment to developing high-quality biological products, ensuring that our customers receive reliable tools that can propel scientific inquiry and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.